Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.

Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB.

Am J Respir Crit Care Med. 2003 Jul 1;168(1):121-5. Epub 2003 Apr 2.

PMID:
12672648
2.

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.

Shitrit D, Bendayan D, Gidon S, Saute M, Bakal I, Kramer MR.

J Heart Lung Transplant. 2005 Sep;24(9):1440-3.

PMID:
16143268
3.

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.

Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T.

Transplantation. 2008 Jan 15;85(1):36-41. doi: 10.1097/01.tp.0000295981.84633.bc.

PMID:
18192909
4.

Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.

Porhownik NR, Batobara W, Kepron W, Unruh HW, Bshouty Z.

Can Respir J. 2008 May-Jun;15(4):199-202.

5.
6.

Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.

Kingah PL, Muma G, Soubani A.

Clin Transplant. 2014 Aug;28(8):906-10. doi: 10.1111/ctr.12401. Epub 2014 Jul 9.

PMID:
24931185
7.

A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.

Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C.

Thorax. 2015 May;70(5):442-50. doi: 10.1136/thoraxjnl-2014-205998. Epub 2015 Feb 24.

8.

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.

Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE.

Am J Respir Crit Care Med. 2006 Sep 1;174(5):566-70. Epub 2006 Jun 1.

PMID:
16741151
9.

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.

Verleden GM, Dupont LJ.

Transplantation. 2004 May 15;77(9):1465-7.

PMID:
15167610
10.

Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.

Dusmet M, Maurer J, Winton T, Kesten S.

J Heart Lung Transplant. 1996 Sep;15(9):948-54.

PMID:
8889991
11.

Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?

Vos R, Vanaudenaerde BM, Ottevaere A, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Wauters S, Van Raemdonck DE, Nawrot TS, Dupont LJ, Verleden GM.

J Heart Lung Transplant. 2010 Dec;29(12):1358-68. doi: 10.1016/j.healun.2010.05.023. Epub 2010 Jul 8.

PMID:
20619683
12.

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.

Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM.

Eur Respir J. 2008 Oct;32(4):832-43. doi: 10.1183/09031936.00134307. Review.

13.

Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.

de Wall C, Sabine D, Gregor W, Mark G, Axel H, Thomas F, Tobias W, Jens G.

Respir Med. 2014 Feb;108(2):405-12. doi: 10.1016/j.rmed.2013.12.016. Epub 2014 Jan 8.

14.

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.

Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, Lordan JL, Dark JH, Corris PA.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):772-5. Epub 2005 Jun 23.

PMID:
15976371
15.

Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ.

J Heart Lung Transplant. 2010 May;29(5):531-7. doi: 10.1016/j.healun.2009.12.003. Epub 2010 Feb 4.

16.

Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study.

Khalid M, Al Saghir A, Saleemi S, Al Dammas S, Zeitouni M, Al Mobeireek A, Chaudhry N, Sahovic E.

Eur Respir J. 2005 Mar;25(3):490-3.

17.

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.

Pirzada OM, McGaw J, Taylor CJ, Everard ML.

J Cyst Fibros. 2003 Jun;2(2):69-71.

18.

Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.

Crowley S, Egan JJ.

Expert Rev Anti Infect Ther. 2005 Dec;3(6):923-30. Review.

PMID:
16307505
19.

International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.

Sarahrudi K, Estenne M, Corris P, Niedermayer J, Knoop C, Glanville A, Chaparro C, Verleden G, Gerbase MW, Venuta F, Böttcher H, Aubert JD, Levvey B, Reichenspurner H, Auterith A, Klepetko W.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1126-32.

20.

Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?

Verleden GM, Dupont LJ, Van Raemdonck DE.

Eur Respir J. 2005 Feb;25(2):221-4. Review.

Supplemental Content

Support Center